KERX Financial Facts
Net loss: -2.06MLoss before income taxes: -2.06M
See Full Income Statement
Other current assets: 1.74M
Additional paid-in capital: 478.81M
See Full Balance Sheet
Earnings History for Keryx Biopharmaceuticals Inc. (KERX)
|
Expand Research on KERX
| Next EPS Date | 8/6/13 *Est. | EPS Growth Rate | +76.9% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -37.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.4% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/7/13 | Q113 | -$0.03 | -$0.01 | -$0.02 | $7M | $5.83M | N/A / N/A | N/A | -4.1% | Details | |
8/8/11  |
Q211 | -$0.05 | -$0.03 | -$0.02 | $5M | $5M | N/A / N/A | N/A | +120.1% | Details | |
| 3/8/11 |
 |
Q410 | -$0.09 | -$0.06 | -$0.03 | N/A | $2.82M | N/A / N/A | N/A | +92.5% | Details |
| 11/2/11 |
|
Q311 | -$0.15 | -$0.12 | -$0.03 | N/A | N/A | N/A / N/A | N/A | +150.3% | Details |
| 2/29/12 |
|
Q411 | -$0.12 | -$0.14 | +$0.02 | N/A | N/A | N/A / N/A | N/A | +130.7% | Details |
| 5/8/12 | Q112 | -$0.13 | -$0.12 | -$0.01 | N/A | N/A | N/A / N/A | N/A | +443.3% | Details | |
| 3/11/13 |
|
Q412 | -$0.09 | -$0.08 | -$0.01 | N/A | N/A | N/A / N/A | N/A | +4.2% | Details |
| 11/8/12 |
Q312 | -$0.08 | -$0.07 | -$0.01 | N/A | N/A | N/A / N/A | N/A | +223.2% | Details |
